EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

What’s new in pediatric bone sarcomas and benign bone tumors

Nicolas von der Weid iD, Daniel Baumhoer, Andreas H Krieg iD

Journal of Children's Orthopaedics · 2026-08 · 20 (4) · 359-370

DOI: 10.1177/18632521261444250 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Children's Orthopaedics, online erschienen am 27.04.2026. Verfasst von Nicolas von der Weid und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Hematology-Oncology Department, University Children's Hospital and University of Basel, Basel, Switzerland. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Significant progress has been made in the diagnosis and treatment of pediatric bone tumors in recent years. For malignant bone tumors, a better understanding of the molecular pathogenesis has been achieved, providing new directions for targeted approaches and immunotherapy. Advances in imaging techniques, such as whole-body magnetic resonance imaging and fluorodeoxyglucose-positron emission tomography/computed tomography, have improved the accuracy of staging, treatment response evaluation, and recurrence monitoring. In surgical treatment, 3D printing technology, computer navigation, and minimally invasive techniques have shifted the paradigm from resection to functional reconstruction. Technologies, including modular and expandable implants, along with bio-integrated prostheses, support long-term functional recovery in pediatric patients. For benign bone tumors, the use of targeted drugs like denosumab and the refinement of minimally invasive techniques such as cryotherapy and radiofrequency ablation have achieved a better balance between disease control and functional preservation. The ongoing development of multidisciplinary collaboration further optimizes personalized treatment strategies. Looking ahead, continuous progress in precision medicine will steer the diagnosis and treatment of pediatric bone tumors toward minimally invasive, individualized, and innovative approaches.

Schlagwörter

Stichwörter der Autor:innen

Pediatric bone tumorsimmunotherapymolecular diagnosisprecision medicinetargeted therapy

Autor:innen und Institutionen

  • Pediatric Hematology-Oncology Department, University Children's Hospital and University of Basel, Basel, Switzerland.
  • Bone and Soft Tissue Tumor Center of the University of Basel (KWUB), Basel, Switzerland.
  • Bone Tumor Reference Center, University Hospital Basel, Basel, Switzerland.
  • Basel Research Centre for Child Health (BRCCH), University of Basel and ETH Zurich, Basel, Switzerland.
  • Department of Orthopedics, University Children's Hospital (UKBB), Basel, Switzerland.

ORCID-Profile: Nicolas von der Weid, Andreas H Krieg

Zitieren

APA

von der Weid, N., Baumhoer, D., & Krieg, A. H. (2026). What’s new in pediatric bone sarcomas and benign bone tumors. Journal of Children's Orthopaedics, 20(4), 359-370. https://doi.org/10.1177/18632521261444250

Vancouver

von der Weid N, Baumhoer D, Krieg AH. What’s new in pediatric bone sarcomas and benign bone tumors. Journal of Children's Orthopaedics. 2026;20(4):359-370. doi:10.1177/18632521261444250

BibTeX
@article{vonderWeid2026,
  author = {von der Weid, Nicolas and Baumhoer, Daniel and Krieg, Andreas H},
  title = {What’s new in pediatric bone sarcomas and benign bone tumors},
  journal = {Journal of Children's Orthopaedics},
  year = {2026},
  volume = {20},
  number = {4},
  pages = {359--370},
  doi = {10.1177/18632521261444250}
}
Kostenlos starten →